Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction
Conditions: Ferric Carboxymaltose; Heart Failure With Reduced Ejection Fraction; Arrhythmias, Cardiac Intervention: Drug: Ferric carboxymaltose Sponsor: Aristotle University Of Thessaloniki Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2) —study protocol for a randomised controlled trial
This study aims to evaluate whether a web-based relapse management programme will positively change relapse management and strengthen autonomy in people with multiple sclerosis.MethodsThe pragmatic double-blind randomised controlled trial is accompanied by a mixed-methods process evaluation and a health economic evaluation and follows the UK Medical Research Council guidance on developing and evaluating complex interventions. A total of 188 people with possible or relapsing-remitting multiple sclerosis with ≥ 1 relapse within the last year and/or ≥ 2 relapses within the last 2 years will be recruited and randomise...
Source: Trials - February 14, 2021 Category: Research Source Type: clinical trials
Scynexis Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerp's Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV Therapies
JERSEY CITY, N.J., Jan. 30, 2019 /PRNewswire/ -- Scynexis, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 30, 2019 Category: Pharmaceuticals Source Type: clinical trials
Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial
ConclusionA large RCT of CSD + CHG and TA + SPU (but not PAL + CHG + Tape) versus standard care is feasible.Trial registrationAustralian and New Zealand Clinical Trials Registry,ACTRN12616000027415. Registered on 15 January 2016. (Source: Trials)
Source: Trials - October 4, 2017 Category: Research Source Type: clinical trials
